CXCL12 is considered proatherogenic because of its involvement in dyslipidaemia, angiogenesis, plaque destabilization, thrombus formation, neointimal hyperplasia, and proinflammatory effects on the vascular endothelium [62]. This evidence concerns the gene CXCL12 and inherited lipid metabolism disorder.